drugset / Trial / NCT00465803
A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to assess patient compliance with DuoTrav versus concomitant administration of Timolol 0.5% plus TRAVATAN in patients with open-angle glaucoma or ocular hypertension.
Timeline
- Start
- 2007-03
- Primary completion
- 2009-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Timolol | Other / unclassified | 0.5 % | Other |
| Subject | Travoprost | Other / unclassified | 0.004 % | Other |